222 related articles for article (PubMed ID: 19853616)
1. In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection.
Ugai H; Wang M; Le LP; Matthews DA; Yamamoto M; Curiel DT
J Mol Biol; 2010 Jan; 395(1):55-78. PubMed ID: 19853616
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging.
Borovjagin AV; McNally LR; Wang M; Curiel DT; MacDougall MJ; Zinn KR
Mol Imaging; 2010 Apr; 9(2):59-75. PubMed ID: 20236604
[TBL] [Abstract][Full Text] [Related]
3. Core labeling of adenovirus with EGFP.
Le LP; Le HN; Nelson AR; Matthews DA; Yamamoto M; Curiel DT
Virology; 2006 Aug; 351(2):291-302. PubMed ID: 16678874
[TBL] [Abstract][Full Text] [Related]
4. Fluorescently labeled adenovirus with pIX-EGFP for vector detection.
Le LP; Everts M; Dmitriev IP; Davydova JG; Yamamoto M; Curiel DT
Mol Imaging; 2004 Apr; 3(2):105-16. PubMed ID: 15296675
[TBL] [Abstract][Full Text] [Related]
5. Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX.
Tang Y; Le LP; Matthews QL; Han T; Wu H; Curiel DT
Virology; 2008 Aug; 377(2):391-400. PubMed ID: 18570971
[TBL] [Abstract][Full Text] [Related]
6. Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein.
Le LP; Li J; Ternovoi VV; Siegal GP; Curiel DT
J Gen Virol; 2005 Dec; 86(Pt 12):3201-3208. PubMed ID: 16298964
[TBL] [Abstract][Full Text] [Related]
7. Derivation of a triple mosaic adenovirus for cancer gene therapy.
Tang Y; Wu H; Ugai H; Matthews QL; Curiel DT
PLoS One; 2009 Dec; 4(12):e8526. PubMed ID: 20046872
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent protein tagging of adenoviral proteins pV and pIX reveals 'late virion accumulation compartment'.
Pfitzner S; Hofmann-Sieber H; Bosse JB; Franken LE; Grünewald K; Dobner T
PLoS Pathog; 2020 Jun; 16(6):e1008588. PubMed ID: 32584886
[TBL] [Abstract][Full Text] [Related]
9. Novel infectivity-enhanced oncolytic adenovirus with a capsid-incorporated dual-imaging moiety for monitoring virotherapy in ovarian cancer.
Kimball KJ; Rivera AA; Zinn KR; Icyuz M; Saini V; Li J; Zhu ZB; Siegal GP; Douglas JT; Curiel DT; Alvarez RD; Borovjagin AV
Mol Imaging; 2009; 8(5):264-77. PubMed ID: 19796604
[TBL] [Abstract][Full Text] [Related]
10. Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.
Matthews QL; Sibley DA; Wu H; Li J; Stoff-Khalili MA; Waehler R; Mathis JM; Curiel DT
Mol Imaging; 2006; 5(4):510-9. PubMed ID: 17150163
[TBL] [Abstract][Full Text] [Related]
11. Stepwise loss of fluorescent core protein V from human adenovirus during entry into cells.
Puntener D; Engelke MF; Ruzsics Z; Strunze S; Wilhelm C; Greber UF
J Virol; 2011 Jan; 85(1):481-96. PubMed ID: 21047958
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive visualization of adenovirus replication with a fluorescent reporter in the E3 region.
Ono HA; Le LP; Davydova JG; Gavrikova T; Yamamoto M
Cancer Res; 2005 Nov; 65(22):10154-8. PubMed ID: 16287998
[TBL] [Abstract][Full Text] [Related]
13. Human Adenovirus Core Protein V Is Targeted by the Host SUMOylation Machinery To Limit Essential Viral Functions.
Freudenberger N; Meyer T; Groitl P; Dobner T; Schreiner S
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167340
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Visualization of Parental and Progeny Viruses by a Capsid-Specific HaloTag Labeling Strategy.
Liu AA; Zhang Z; Sun EZ; Zheng Z; Zhang ZL; Hu Q; Wang H; Pang DW
ACS Nano; 2016 Jan; 10(1):1147-55. PubMed ID: 26720596
[TBL] [Abstract][Full Text] [Related]
15. Fusion of Large Polypeptides to Human Adenovirus Type 5 Capsid Protein IX Can Compromise Virion Stability and DNA Packaging Capacity.
Poulin KL; McFall ER; Chan G; Provost NB; Christou C; Smith AC; Parks RJ
J Virol; 2020 Aug; 94(17):. PubMed ID: 32522855
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation.
Rosa-Calatrava M; Puvion-Dutilleul F; Lutz P; Dreyer D; de Thé H; Chatton B; Kedinger C
EMBO Rep; 2003 Oct; 4(10):969-75. PubMed ID: 14528266
[TBL] [Abstract][Full Text] [Related]
17. Bovine adenovirus type 3 containing heterologous protein in the C-terminus of minor capsid protein IX.
Zakhartchouk A; Connors W; van Kessel A; Tikoo SK
Virology; 2004 Mar; 320(2):291-300. PubMed ID: 15016551
[TBL] [Abstract][Full Text] [Related]
18. [A comparative analysis of the methods for titering adenoviruses].
Sun PY; Zhang YL; Jing YM; Zhang XJ; Zhang ZH; Li CY; Chen BH; Tan WL; Li HW
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):234-8. PubMed ID: 21354900
[TBL] [Abstract][Full Text] [Related]
19. Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX.
Vellinga J; Rabelink MJ; Cramer SJ; van den Wollenberg DJ; Van der Meulen H; Leppard KN; Fallaux FJ; Hoeben RC
J Virol; 2004 Apr; 78(7):3470-9. PubMed ID: 15016870
[TBL] [Abstract][Full Text] [Related]
20. Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1.
Ugai H; Dobbins GC; Wang M; Le LP; Matthews DA; Curiel DT
Virology; 2012 Oct; 432(2):283-95. PubMed ID: 22717133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
